Oral Antibiotics for Treatment of Gram-Negative Bacteremia in Solid Organ Transplant Recipients: A Propensity Score Weighted Retrospective Observational Study
Clinical Infectious Diseases · 2024
DOI: 10.1093/cid/ciae007 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Clinical Infectious Diseases, 2024. Verfasst von Eliezer Zachary Nussbaum und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Bacteremia, Anti-Bacterial Agents, Propensity Score, Gram-Negative Bacterial Infections. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
Background
We assessed the safety and efficacy of oral antibiotic step-down therapy for uncomplicated gram-negative blood stream infections in solid-organ transplant recipients.
Methods
We identified all solid-organ transplant recipients within the Massachusetts General and Brigham and Women's Hospital systems from 2016 to 2021 with uncomplicated gram-negative bacteremia involving an organism susceptible to an acceptably bioavailable oral antibiotic agent. Using inverse probability of treatment-weighted models based on propensity scores adjusting for potential clinical confounders, we compared outcomes of those transitioned to oral antibiotics with those who continued intravenous (IV) therapy for the duration of treatment. Primary endpoints were mortality, bacteremia recurrence, and reinitiation of IV antibiotics. Secondary endpoints included length of stay, Clostridioides difficile infection, treatment-associated complications, and tunneled central venous catheter placement.
Results
A total of 120 bacteremia events from 107 patients met inclusion criteria in the oral group and 42 events from 40 patients in the IV group. There were no significant differences in mortality, bacteremia recurrence, or reinitiation of IV antibiotics between groups. Patients transitioned to oral antibiotics had an average length of stay that was 1.97 days shorter (95% confidence interval [CI], −.39 to 3.56 days; P = .005). Odds of developing C. difficile and other treatment-associated complications were 8.4 times higher (95% CI, 1.5–46.6; P = .015) and 6.4 times higher (95% CI, 1.9–20.9; P = .002), respectively, in the IV group. Fifty-five percent of patients in the IV group required tunneled catheter placement. There was no difference in treatment duration between groups.
Conclusions
Oral step-down therapy was effective and associated with fewer treatment-related adverse events.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, Massachusetts, USA.
- Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
- Department of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
ORCID-Profile: Eliezer Zachary Nussbaum, Camille N Kotton
Zitieren
APA
Nussbaum, E. Z., Koo, S., & Kotton, C. N. (2024). Oral Antibiotics for Treatment of Gram-Negative Bacteremia in Solid Organ Transplant Recipients: A Propensity Score Weighted Retrospective Observational Study. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciae007
Vancouver
Nussbaum EZ, Koo S, Kotton CN. Oral Antibiotics for Treatment of Gram-Negative Bacteremia in Solid Organ Transplant Recipients: A Propensity Score Weighted Retrospective Observational Study. Clinical Infectious Diseases. 2024. doi:10.1093/cid/ciae007
BibTeX
@article{Nussbaum2024,
author = {Nussbaum, Eliezer Zachary and Koo, Sophia and Kotton, Camille N},
title = {Oral Antibiotics for Treatment of Gram-Negative Bacteremia in Solid Organ Transplant Recipients: A Propensity Score Weighted Retrospective Observational Study},
journal = {Clinical Infectious Diseases},
year = {2024},
doi = {10.1093/cid/ciae007}
}
EUVIMED